ROMANIAN EXPERIENCE WITH MANAGED ENTRY AGREEMENTS FOR DRUGS

被引：0
|
作者：
Radu, P. [1 ]
Stoica, I [1 ]
Udroiu, P. [1 ]
机构：
[1] Roche Romania SRL, Bucharest, Romania
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1247
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP353
引用
收藏
页码：S210 / S211
页数：3
相关论文
共 50 条
  • [1] MANAGED ENTRY AGREEMENTS: PORTUGUESE EXPERIENCE
    Goncalves, L.
    Teixeira, M.
    Caldeira, S.
    Ramos, R.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A500 - A500
  • [2] MANAGED ENTRY AGREEMENTS FOR PRESCRIPTION DRUGS IN SWEDEN
    Gregorsson, M.
    Medin, E.
    Lindblom, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S800 - S800
  • [3] Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future
    Pauwels, Kim
    Huys, Isabelle
    Vogler, Sabine
    Casteels, Minne
    Simoens, Steven
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [4] Managed entry agreements
    Luisa AA Muscolo
    Claudia Bernardini
    Paolo D Siviero
    Simona Montilla
    Luca Pani
    [J]. Orphanet Journal of Rare Diseases, 9 (Suppl 1)
  • [5] THE IMPACT ON ACCESS TO INNOVATIVE DRUGS OF THE FIRST MANAGED ENTRY AGREEMENTS IN ROMANIA
    Chiriac, N. D.
    Radu, P. C.
    Pravat, M. A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A503 - A503
  • [6] HOW TO DEAL WITH DECISION UNCERTAINTY? THE ITALIAN EXPERIENCE WITH MANAGED ENTRY AGREEMENTS
    Siviero, P. D.
    Sammarco, A.
    Tafuri, G.
    Pani, L.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A31 - A31
  • [7] Risk sharing in managed entry agreements-A review of the Swedish experience
    Andersson, Emelie
    Svensson, Johanna
    Persson, Ulf
    Lindgren, Peter
    [J]. HEALTH POLICY, 2020, 124 (04) : 404 - 410
  • [8] Healthcare Systems across Europe and the US: The Managed Entry Agreements Experience
    Ciulla, Michele
    Marinelli, Lisa
    Di Biase, Giuseppe
    Cacciatore, Ivana
    Santoleri, Fiorenzo
    Costantini, Alberto
    Dimmito, Marilisa Pia
    Di Stefano, Antonio
    [J]. HEALTHCARE, 2023, 11 (03)
  • [9] MANAGING UNCERTAINTY FOR THE ORPHANS: A BELGIAN PERSPECTIVE ON MANAGED ENTRY AGREEMENTS FOR ORPHAN DRUGS
    Blonda, A.
    Denier, Y.
    Huys, I
    Simoens, S.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S255 - S255
  • [10] Managed entry agreements for pharmaceuticals in Australia
    Vitry, Agnes
    Roughead, Elizabeth
    [J]. HEALTH POLICY, 2014, 117 (03) : 345 - 352
12345